SOX2 levels were positively correlated with p53 positivity in colorectal (r = 0.60, p < 0.01) and breast cancer (r = 0.55, p < 0.01), although the functional implications of this association remain uncertain, as p53 IHC cannot distinguish between mutant and wild-type forms. This evidence concerns the gene SOX2 and breast carcinoma.